国产精品国产三级区别第一集,亚洲精品国产成人,精品人妻无码一区二区三区,人妻熟妇乱又伦精品视频

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點(diǎn)擊次數(shù):3318

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報(bào)道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
欧美| 国产成人精品一区二三区在线观看| 人妻少妇偷人精品无码洋洋av| 日韩精品无码视频一区二区蜜桃| 国产在线国偷精品产拍| 亚洲 欧美 中文 日韩aⅴ| 久久亚洲精品中文字幕| 久久亚洲精品成人AV无码网站| 中文字幕高清免费日韩视频在线 | 亚洲精品久久激情国产片 | 亚洲国产一区二区三区在线观看| 国产最新精品SM调教视频| 久久久精品中文字幕麻豆发布| 日本真人添下面视频免费| 国产网红女主播精品视频| 亚洲 自拍 另类 欧美 综合| 亚洲精品在线观看| 亚洲av无码av吞精久久| 成全视频在线观看免费观看| 国产中文精品无码欧美综合小说| AV亚洲产国偷V产偷V自拍| 国产娇小粉嫩学生免费网站| 99热精品久久只有精品| 国产JJIZZ女人多水免费| 无码少妇一区二区三区| 免费视频网站| 国产成人无码18禁午夜福利P| 久久精品免视看国产成人不卡| 猫咪亚洲精品无码MV在线观看| 少妇一晚三次一区二区三区| 久久精品国产亚洲AV高清| 性色A∨亚洲一区二区三区| 无码人妻精品一区二区三区99| 国产一区二三区好的精华液| 精人妻无码一区二区三区| 亚洲av无码一区二区三区系列| 日本精品一区二区三区| 少妇老师寂寞高潮免费a片| 精品乱码久久久久久久| 天天躁日日躁狠狠躁欧美老妇| 免费网站看v片在线18禁无码|